Nicotinamide for rheumatoid arthritis: a clinical trial
Treatments studied
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This trial tests if taking a vitamin B3 supplement (nicotinamide) can improve outcomes for people with rheumatoid arthritis. Researchers want to see if adding this over-the-counter vitamin to your usual arthritis medicines helps reduce disease activity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old and have been diagnosed with rheumatoid arthritis.
- Your arthritis is moderately or highly active (meaning you have noticeable joint swelling/pain).
- You have been taking the same arthritis medications (like methotrexate or sulfasalazine) for at least 3 months.
- You are not currently taking a biologic drug for arthritis or any extra vitamin B3/nicotinamide.
- You are not pregnant or breastfeeding, and you do not have other autoimmune diseases (like lupus).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new investigational drug called Natrunix, when combined with your usual methotrexate, can improve symptoms of moderate to severe rheumatoid arthritis. The goal is to reduce joint pain and swelling and help you feel better.
This study tests whether adding vitamin E to standard rheumatoid arthritis treatment can reduce inflammation and disease activity. It is designed for women with early RA who are not getting enough vitamin E from their diet.
This study tests a medicine called nicorandil, which is normally used for chest pain, to see if it can lower the risk of heart disease in people with rheumatoid arthritis. If you have RA and are already on standard treatment, this may help protect your heart.
This study tests whether nicorandil, a heart medication with anti-inflammatory properties, can help reduce joint inflammation and swelling in people with active rheumatoid arthritis who are already taking conventional disease-modifying drugs. The goal is to see if it provides additional relief from symptoms.
This study tests whether a heart medication called nicorandil can help reduce arthritis symptoms when added to your current treatment. It is for people with moderate to severe rheumatoid arthritis who have been stable on their current treatments.
This trial tests whether adding L-carnitine (a natural substance) to your current treatment helps reduce rheumatoid arthritis symptoms. It could be an option if your arthritis is still active despite taking standard medications.
Hear when a new Rheumatoid arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.